EFFICACY AND SAFETY OF LEVOLET IN PATIENTS WITH ACUTE BACTERIAL RHINOSINUSITIS AND EXACERBATIONS OF CHRONIC PURULENT RHINOSINUSITIS
- Authors: Angotoeva I.B.1, Angotoyeva IB1
-
Affiliations:
- Issue: No 10 (2011)
- Pages: 60-64
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278898
- ID: 278898
Cite item
Full Text
Abstract
The article presents the results of study involving 20 patients with acute and chronic rhinosinusitis. The study was aimed to evaluation of efficacy and safety of levofloxacin (Levolet) for the treatment of such patients. Levofloxacin was used for 10 days at a dose of 500 mg/day. The study showed that the drug Levolet is effective in the treatment of acute bacterial rhinosinusitis and exacerbations of chronic rhinosinusitis and well tolerated.
References
- Лопатин А.С., Гамов В.П. Острый и хронический риносинусит: этиология, патогенез, клиника, диагностика и принципы лечения. М., 2011.
- Fokkens W, et al. Role of steroids in the treatment of rhinosinusitis with and without polyposis. Clin Allergy Immunol 2007;20:241-50.
- European Position Paper on Rhinosinusitis and Nasal Polyps, 2007
- Schoenwetter WF, et al. Economic impact and quality-of-life burden of allergic rhinitis. Curr Med Res Opin 2004;20:305-17.
- Bhattacharyya N. Bacterial infection in chronic rhinosinusitis: A controlled paired analysis. Am J Rhinol 2005;19(6):544-8
- Araujo E, Palombini BC, Cantarelli V, et al. Microbiology of middle meatus in chronic rhinosinusitis. Am J Rhinol 2003;17(1):9-15.
- Spyropoulu-Vlahou M, et al. Acta Terapeutica 1990;16:77-8.
- Lacroix JS. Airway Epithelial (Nasal) Cell Monolayers Used To Study Pseudomonas aeruginosa Invasion Are Hyperpolarized and Not Representative of the Human Airway Epithelium. Infect Immun. 2006;74(12):7043-44.
Supplementary files
